Jalal Jalaly, MD
Pathology and Laboratory Medicine
Sees patients age 18 and up
Penn Pathology and Laboratory Medicine HUP
Penn Medicine Provider

About me

  • Associate Professor of Clinical Pathology and Laboratory Medicine

Education and training

  • Medical School: King Saud University
  • Residency: Barnes-Jewish Hospital - Washington University, St. Louis
  • Fellowship: Barnes-Jewish Hospital - Washington University, St. Louis
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Jalaly is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Basu D, Sannigrahi MK, Raghav L, Rajagopalan P, Brody R, Jalaly J, Gallant JN Evidence of a role for oropharyngeal cancer cells with low HPV gene expression in treatment failure , Journal of Clinical Oncology (ASCO): 2025


Hieromnimon HM, Trzcinska A, Wen F, Howard FM, Dolezal JM, Dyer E, Kochanny S, Schulte J, Wang C, Chen H, Chin J, …, Jalaly JB, et al Interpretable HPV detection in head and neck cancer using foundation models and synthetic digital pathology , Cancer Research: 2025


Sannigrahi MK, Raghav L, Rich DJ, Schrank TP, Califano JA, Lukens JN, Sun L, Morgan IM, Cohen RB, Lin A, Liu X…, Jalaly JB, et al Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer , JNCI: Journal of the National Cancer Institute: 2025


Hieromnimon HM, Trzcinska A, Wen FT, Howard FM, Dolezal JM, Dyer E, Kochanny S, Schulte JJ, Wang C, Chen H, Chin J, Blair E, Agrawal N, Rosenberg A, Vokes E, Katipally R, Juloori A, Izumchenko E, Lingen MW, Cipriani N, Jalaly JB, Basu D, Riesenfeld SJ, Pearson AT Analysis of AI foundation model features decodes the histopathologic landscape of HPV-positive head and neck squamous cell carcinomas , Oral Oncology, 163: 2025


Jalaly JB MMP11 as a Prognostic Indicator for Inverted Papilloma Histologic Grade and Recurrence , The Laryngoscope: 2025


Rossi ED, Agarwal S, Erkilic S, Hang JF, Jalaly JB, Khanafshar E, Ladenheim A, Baloch Z Psammoma bodies in thyroid: are they always indicative of malignancy? A multi-institutional study , Virchows Archiv, 485: 2024


Sannigrahi, Malay K., ..., Jalaly JB, et al Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instability. , bioRxiv: 2024


Resta IT, Jalaly JB Mucosal neuroma , Pathology Outlines : 2024


Tong CCL, Lin X, Seckar T, Koptyra M, Kohanski MA, Cohen NA, Kennedy DW, Adappa ND, Papagiannopoulos P, Kuan EC, Baranov E, Jalaly JB, Feldman MD, Storm PB, Resnick AC, Palmer JN, Wei Z, Robertson ES. A Metagenomic Analysis of the Virome of Inverted Papilloma and Squamous Cell Carcinoma. , Int Forum Allergy Rhinol, 13(11): 2023,2055-2062


Jalaly JB, Baloch ZW. Salivary Gland Neoplasms in Small Biopsies and Fine Needle Aspirations. , Semin Diagn Pathol, 40(5): 2023,340-348


View all publications